Legacy Citation Support
21 U.S.C. § 3601
This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.
Use the current title page and nearby sections below to continue browsing Title 21. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.
Nearby current sections
- § 357 — Qualification of drug development tools
- § 358 — Authority to designate official names
- § 359 — Nonapplicability of subchapter to cosmetics
- § 360 — Registration of producers of drugs or devices
- § 360a — Clinical trial guidance for antibiotic drugs
- § 360aa — Recommendations for investigations of drugs for rare diseases or conditions
- § 360aaa to 360aaa–6 — Omitted
- § 360a–1 — Clinical trials